DRIO DARIOHEALTH CORP revenue, earnings and financials
For the quarter ended June 30, 2026, DARIOHEALTH CORP reported revenue of $5.18M (down 3.6% from a year earlier), net income of −$7.92M and diluted EPS of $0.85; over the last four quarters revenue was $21.0M and net income −$35.7M; for the fiscal year ended December 2025 revenue was $22.4M, down 17.3% on the year before.
DRIO annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $22.4M, gross profit $12.7M, operating income −$36.7M, net income −$41.7M (margin -186.6%), EPS $10.12
- Fiscal year ended Dec 2024: revenue $27.0M, gross profit $13.3M, operating income −$57.7M, net income −$42.7M (margin -158.1%), EPS $12.27
- Fiscal year ended Dec 2023: revenue $20.4M, gross profit $5.98M, operating income −$56.2M, net income −$59.4M (margin -292.0%), EPS $1.93
- Fiscal year ended Dec 2022: revenue $27.7M, gross profit $9.66M, operating income −$56.8M, net income −$62.2M (margin -224.9%), EPS $2.54
- Fiscal year ended Dec 2021: revenue $20.5M, gross profit $3.96M, operating income −$76.5M, net income −$76.8M (margin -374.2%), EPS $4.07
DRIO quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $5.18M (down 3.6% year over year), net income −$7.92M, EPS $0.85
- Quarter ended Mar 31, 2026: revenue $5.58M (down 17.3% year over year), net income −$8.25M, EPS $1.25
- Quarter ended Dec 31, 2025 (from the annual report): revenue $5.23M (down 31.2% year over year), net income −$9.03M, EPS $0.75
- Quarter ended Sep 30, 2025: revenue $5.01M (down 32.5% year over year), net income −$10.5M, EPS $2.96
- Quarter ended Jun 30, 2025: revenue $5.37M (down 14.2% year over year), net income −$13.0M, EPS $3.54
- Quarter ended Mar 31, 2025: revenue $6.75M (up 17.3% year over year), net income −$9.23M, EPS $2.87
- Quarter ended Dec 31, 2024 (from the annual report): revenue $7.60M (up 110.3% year over year), net income −$9.63M, EPS $7.08
- Quarter ended Sep 30, 2024: revenue $7.42M (up 111.0% year over year), net income −$12.3M, EPS $4.91
- Quarter ended Jun 30, 2024: revenue $6.26M (up 1.7% year over year), net income −$13.6M, EPS $0.08
- Quarter ended Mar 31, 2024: revenue $5.76M (down 18.5% year over year), net income −$7.18M, EPS $0.20
- Quarter ended Dec 31, 2023 (from the annual report): revenue $3.62M (down 46.9% year over year), net income −$14.3M, EPS $0.41
- Quarter ended Sep 30, 2023: revenue $3.52M (down 46.7% year over year), net income −$15.7M, EPS $0.49
- Quarter ended Jun 30, 2023: revenue $6.15M (down 0.5% year over year), net income −$16.6M, EPS $0.58
- Quarter ended Mar 31, 2023: revenue $7.07M (down 12.3% year over year), net income −$12.8M, EPS $0.45
- Quarter ended Dec 31, 2022 (from the annual report): revenue $6.81M (up 13.0% year over year), net income −$12.6M, EPS $0.42
- Quarter ended Sep 30, 2022: revenue $6.61M (up 17.3% year over year), net income −$15.6M, EPS $0.64
- Quarter ended Jun 30, 2022: revenue $6.18M (up 17.5% year over year), net income −$18.0M, EPS $0.74
- Quarter ended Mar 31, 2022: revenue $8.06M (up 124.2% year over year), net income −$15.9M, EPS $0.74
- Quarter ended Dec 31, 2021 (from the annual report): revenue $6.03M, net income −$21.6M, EPS $0.98
- Quarter ended Sep 30, 2021: revenue $5.63M, net income −$22.4M, EPS $1.18
DRIO cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$25.9M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$38.6M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$30.4M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$47.8M, share buybacks $134K
- Fiscal year ended Dec 2021: operating cash flow −$50.4M, share buybacks n/a
DRIO balance sheet
- Jun 30, 2026: cash $6.63M, total assets $96.6M, total liabilities n/a, shareholders' equity $55.1M, long-term debt $31.1M
- Mar 31, 2026: cash $15.0M, total assets $103M, total liabilities n/a, shareholders' equity $62.4M, long-term debt $30.9M
- Dec 31, 2025: cash $21.8M, total assets $110M, total liabilities n/a, shareholders' equity $67.9M, long-term debt $30.7M
- Sep 30, 2025: cash $31.9M, total assets $118M, total liabilities n/a, shareholders' equity $74.9M, long-term debt $30.6M
- Jun 30, 2025: cash $22.0M, total assets $108M, total liabilities n/a, shareholders' equity $64.0M, long-term debt $30.5M
- Mar 31, 2025: cash $27.9M, total assets $116M, total liabilities n/a, shareholders' equity $73.7M, long-term debt $18.9M
- Dec 31, 2024: cash $27.8M, total assets $119M, total liabilities n/a, shareholders' equity $72.0M, long-term debt $23.5M
- Sep 30, 2024: cash $15.5M, total assets $110M, total liabilities n/a, shareholders' equity $58.5M, long-term debt $20.2M
What is DRIO's revenue?
DARIOHEALTH CORP reported $21.0M of revenue over its last four quarters, through June 30, 2026.
Is DRIO profitable?
No. DARIOHEALTH CORP lost $35.7M over the last four quarters.
What is DRIO's EPS?
Diluted earnings per share over the last four quarters were $5.81; $0.85 in the latest quarter.